AWP Reform Will Include Manufacturer Price Reporting, CMS Predicts
Executive Summary
Pharmaceutical manufacturers should prepare to adopt a new market price reporting system to replace the current AWP methodology used for Medicare Part B reimbursement, CMS' Center for Medicare Management Director Thomas Grissom said Nov. 13
You may also be interested in...
PhRMA Priorities After Medicare Rx: “Access And Affordability”
The Pharmaceutical Research & Manufacturers of America is adding "affordability" to "access" as a key theme of its advocacy agenda
PhRMA Priorities After Medicare Rx: “Access And Affordability”
The Pharmaceutical Research & Manufacturers of America is adding "affordability" to "access" as a key theme of its advocacy agenda
CMS Expected To Delay AWP Regulation; Medicare Conferees Want Credit
The Centers for Medicare & Medicaid Services is expected to hold off on issuing a final regulation reforming the AWP reimbursement methodology to allow Medicare conferees the chance to complete work on the issue